NT113, A pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification
- Yasuyuki Yoshida
- , Tomoko Ozawa
- , Tsun Wen Yao
- , Wang Shen
- , Dennis Brown
- , Andrew T. Parsa
- , Jeffrey J. Raizer
- , Shi Yuan Cheng
- , Alexander H. Stegh
- , Andrew P. Mazar
- , Francis J. Giles
- , Jann N. Sarkaria
- , Nicholas Butowski
- , Theodore Nicolaides
- , C. David James
- University of California San Francisco
- St. Marianna University School of Medicine
- NewGen Therapeutics, Inc.
- Northwestern University Feinberg School of Medicine
- Northwestern Medicine
- Mayo Clinic College of Medicine and Science
Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
13
Citations
(Scopus)